Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-CTLA-4/CD152 Antibody

Catalog No. T9901A-1254 Copy Product Info
Purity: 95%
🥰Excellent
Anti-CTLA-4/CD152 Antibody is a humanized monoclonal antibody targeting cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4/CD152). This product specifically binds to the extracellular domain of CTLA-4, blocking its interaction with ligands CD80 (B7-1) and CD86 (B7-2). This blockade removes the negative regulatory signal of CTLA-4 on T-cell activation, thereby enhancing T-cell proliferation, cytokine production, and anti-tumor immune responses.

Anti-CTLA-4/CD152 Antibody

Copy Product Info
🥰Excellent
Catalog No. T9901A-1254

Anti-CTLA-4/CD152 Antibody is a humanized monoclonal antibody targeting cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4/CD152). This product specifically binds to the extracellular domain of CTLA-4, blocking its interaction with ligands CD80 (B7-1) and CD86 (B7-2). This blockade removes the negative regulatory signal of CTLA-4 on T-cell activation, thereby enhancing T-cell proliferation, cytokine production, and anti-tumor immune responses.

Anti-CTLA-4/CD152 Antibody
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$247-In Stock
5 mg$695-In Stock
10 mg$1,090-In Stock
25 mg$1,980-In Stock
50 mg$3,280-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:95%
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Anti-CTLA-4/CD152 Antibody is a humanized monoclonal antibody targeting cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4/CD152). This product specifically binds to the extracellular domain of CTLA-4, blocking its interaction with ligands CD80 (B7-1) and CD86 (B7-2). This blockade removes the negative regulatory signal of CTLA-4 on T-cell activation, thereby enhancing T-cell proliferation, cytokine production, and anti-tumor immune responses.
In vitro
Anti-CTLA-4/CD152 Antibody binds the CTLA-4 extracellular domain with high affinity. In T-cell assays, it reverses CD80/CD86-induced CTLA-4 inhibition, increasing IL-2 and IFN-γ production and restoring effector T-cell proliferation [1].
In vivo
In preclinical tumor models, systemic administration of Anti-CTLA-4/CD152 Antibody leads to a reduction in tumor growth and a significant increase in the ratio of effector T cells to regulatory T cells (Tregs) within the tumor microenvironment; the treatment enhances the overall anti-tumor immune response by modulating the inhibitory checkpoints that normally limit T-cell activity during tumor progression [1].
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Uniprot ID
TargetCTLA-4/CD152
Chemical Properties
Antibody Information
IsotypeIgG1
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Anti-CTLA-4/CD152 Antibody | purchase Anti-CTLA-4/CD152 Antibody | Anti-CTLA-4/CD152 Antibody cost | order Anti-CTLA-4/CD152 Antibody | Anti-CTLA-4/CD152 Antibody in vivo | Anti-CTLA-4/CD152 Antibody in vitro